New strategies for novel antibiotics: Peptides targeting bacterial cell membranes

General Physiology and Biophysics

Volumn 28, Issue 2, 2009, Pages 105-116

  Lohner, Karl ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Biomembrane mimetics; Cubic phases; Interdigitation; Lipid segregation; Membrane domains

Indexed keywords

ALAMETHICIN; AMIKACIN; BACITRACIN; CHLORAMPHENICOL; CLINDAMYCIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; GRAMICIDIN S; LANTIBIOTIC; LIPOSOME; MEMBRANE LIPID; MONOBACTAM; OXAZOLIDINONE DERIVATIVE; PENICILLIN G; PEPTIDE; PHOSPHATIDYLCHOLINE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLONE; RIFAMPICIN; RNA POLYMERASE; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL MEMBRANE; CELL MEMBRANE; CHANNEL GATING; CROSS LINKING; DNA REPLICATION; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; INNATE IMMUNITY; LIPID COMPOSITION; MEMBRANE RUPTURE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICELLIZATION; NONHUMAN; PHOSPHOLIPID BILAYER; PROTEIN SYNTHESIS; REVIEW; X RAY DIFFRACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL MEMBRANE; DRUG DESIGN; HUMANS; MEMBRANE LIPIDS; MODELS, BIOLOGICAL;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 67650957816     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2009_02_105     Document Type: Review

References (98)

1. Arouri A., Dathe M., Blume A. (2009): Peptide induced demixing in PG/PE lipid mixtures: A mechanism for the specificity of antimicrobial peptides towards bacterial membranes? Biochim. Biophys. Acta 1788, 650-659; doi:10.1016/j.bbamem.2008.11.022
2. Balgavý P., Uhríková D., Gallová J., Lohner K., Degovics G. (1993): Interaction of tertiary amine anesthetics with phosphatidylcholine bilayers. Prog. Coll. Polym. Sci. 93, 184-185; doi:10.1007/BFb0118503
3. Balgavý P., Devínsky F. (1996): Cut-off effects in biological activities of surfactants. Adv. Colloid Interface Sci. 66, 23-63; doi:10.1016/0001-8686(96)00295-3
4. Balgavý P., Uhríková D., Karlovská P., Dubničková M., Kučerka N., Devínsky F., Lacko I., Čižmárik J., Lohner K., Degovics G., Rapp G., Yaradaikin S., Kiselev M., Islamov A. K., Gordeliy V. I. (2001): X-ray diffraction and neutron scattering studies of amphiphile - lipid bilayer organization. Cell. Mol. Biol. 6, 283-290
5. Bechinger B., Lohner K. (2006): Detergent-like actions of linear amphipathic antimicrobial peptides. Biochim. Biophys. Acta 1758, 1529-1539; doi:10.1016/j.bbamem.2006.07.001
6. Bevers E. M., Comfurius P., Dekkers D. W. C., Zwaal R. F. A. (1999): Lipid translocation across the plasma membrane of mammalian cells. Biochim. Biophys. Acta 1439, 317-330
7. Bogdanov M., Dowhan W. (1995): Phosphatidylethanolamine is required for in vivo function of the membrane-associated lactose permease of Escherichia coli. J. Biol. Chem. 270, 732-739; doi:10.1074/jbc.270.2.732
8. Boman H. G. (1991): Antibacterial peptides: key components needed in immunity. Cell 65, 205-207; doi:10.1016/0092-8674(91)90154-Q
9. Boman H. G. (2003): Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254, 197-215; doi:10.1046/j.1365-2796.2003.01228.x
10. Breukink E., van Kraaij C., Demel A. R., Peelen T., Siezen R., de Kruijff B., Kuipers O. (1997): The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36, 6968-6976; doi:10.1021/bi970008u (Pubitemid 27258109)
11. Chang S., Sievert D. M., Hageman J. C., Boulton M. L., Tenover F. C., Downes F. P., Shah S., Rudrik J. T., Pupp G. R., Brown W. J., Cardo D., Fridkin S. K. (2003): Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med. 348, 1342-1347; doi:10.1056/NEJMoa025025
12. Chen F. Y., Lee M. T., Huang H. W. (2003): Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. Biophys. J. 84, 3751-3758; doi:10.1016/S0006-3495(03)75103-75110
13. Cullis P. R., de Kruijff B. (1979): Lipid polymorphism and the functional roles of lipids in biological membranes. Biochim. Biophys. Acta 559, 399-420
14. de Kruijff B. (1997): Biomembranes. Lipids beyond the bilayer. Nature 386, 129-130; doi:10.1038/386129a0
15. Dathe M., Meyer J., Beyermann M., Maul B., Hoischen C., Bienert M. (2002): General aspects of peptide selectivity towards lipid bilayers and cell membranes studied by variation of the structural parameters of amphipathic helical model peptides. Biochim. Biophys. Acta 1558, 171-186; doi:10.1016/S0005-2736(01)00429-1
16. de Planque M. R., Greathouse D. V., Koeppe R. E., Schafer H., Marsh D., Killian J. A. (1998): Influence of lipid/peptide hydrophobic mismatch on the thickness of diacylphosphatidylcholine bilayers. A 2H NMR and ESR study using designed transmembrane α-helical peptides and gramicidin A. Biochemistry 37, 9333-9345; doi:10.1021/bi980233r
17. Devínsky F., Kopecká-Leitmanová A., Šeršeň F., Balgavý P. (1990): Cut-off effect in antimicrobial activity and in membrane perturbation efficiency of the homologous series of N,N-dimethylalkylamine oxides. J. Pharm. Pharmacol. 42, 790-794
18. El Jastimi R., Lafleur M. (1999): Nisin promotes the formation of non-lamellar inverted phases in unsaturated phosphatidylethanolamine. Biochim. Biophys. Acta. 1418, 97-105; doi:10.1016/S0005-2736(99)00027-9
19. Epand R. F., Umezawa N., Porter E. A., Gellman S. H., Epand R. M. (2003): Interactions of the antimicrobial β-peptide β-17 with phospholipid vesicles differ from membrane interactions of magainins. Eur. J. Biochem. 270, 1240-1248; doi:10.1046/j.1432-1033.2003.03484.x
20. Epand R. F., Schmitt M. A., Gellman S. H., Epand R. M. (2006): Role of membrane lipids in the mechanism of bacterial species selective toxicity by two α/β-antimicrobial peptides. Biochim. Biophys. Acta 1758, 1343-1350; doi:10.1016/j.bbamem.2006.01.018
21. Epand R. F., Mowery B. P., Lee S. E., Stahl S.S., Lehrer R. I., Gellman S. H., Epand R. M. (2008a): Dual mechanism of bacterial lethality for a cationic sequence-random copolymer that mimics host-defense antimicrobial peptides. J. Mol. Biol. 379, 38-50; doi:10.1016/j.jmb.2008.03.047
22. Epand R. M., Rotem S., Mor A., Berno B., Epand R. F. (2008b): Bacterial membranes as a predictor of antimicrobial potency. J. Am. Chem. Soc. 130, 14346-14352; doi:10.1021/ja8062327
23. Epand R. M., Epand R. F. (2009): Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim. Biophys. Acta 1788, 289-294; doi:10.1016/j.bbamem.2008.08.023
24. Enserink M. (2003): Infectious diseases. Resistant staph finds new niches. Science 299, 1639-1641; doi:10.1126/science.299.5613.1639
25. Fluit A. C., Schmitz F.-J. (2003): MRSA: Current Perspectives. Caister Academic Press, Wymondham, Norfolk, U.K.
26. Ganz T., Lehrer R. I. (2001): Antimicrobial peptides in innate immunity. In: Development of Novel Antimicrobial Agents: Emerging Strategies. (Ed. K. Lohner), pp. 139-147, Horizon Scientific Press, Wymondham, Norfolk, U.K.
27. Glover R. E., Smith R. R., Jones M. V., Jackson S. K., Rowlands C. C. (1999): An EPR investigation of surfactant action on bacterial membranes. FEMS Microbiol. Lett. 177, 57-62; doi:10.1111/j.1574-6968.1999.tb13713.x
28. Jean-Francois F., Castano S., Desbat B., Odaert B., Roux M., Metz-Boutigue M. H., Dufourc E. J. (2008): Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains. A new mode of action for antimicrobial peptides? Biochemistry 47, 6394-6402; doi:10.1021/bi800448h
29. Hale J. D., Hancock R. E. (2007): Alternative mechanisms of action of cationic antimicrobial peptides on bacteria. Expert Rev. Anti Infect. Ther. 5, 951-959; doi:10.1586/14787210.5.6.951
30. Hancock R. E., Rozek A. (2002): Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206, 143-149; doi:10.1111/j.1574-6968.2002.tb11000.x
31. Hasper H. E., Kramer N. E., Smith J. L., Hillman J. D., Zachariah C., Kuipers O. P., de Kruijff B., Breukink E. (2006): An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II. Science 313, 1636-1637; doi:10.1126/science.1129818 (Pubitemid 44414037)
32. Hawkey P. M. (2008): Molecular epidemiology of clinically significant antibiotic resistance genes. Br. J. Pharmacol. 153, S406-413; doi:10.1038/sj.bjp.0707632
33. Hays L. M., Crowe J. H., Wolkers W., Rudenko S. (2001): Factors affecting leakage of trapped solutes from phospholipid vesicles during thermotropic phase transitions. Cryobiology 42, 88-102; doi:10.1006/cryo.2001.2307 (Pubitemid 32614080)
34. He K., Ludtke S. J., Heller W. T., Huang H. W (1996): Mechanism of alamethicin insertion into lipid bilayers. Biophys. J. 71, 2669-2679; doi:10.1016/S0006-3495(96)79458-4 (Pubitemid 26367729)
35. Heller W. T., Waring A. J., Lehrer R. I., Harroun T. A., Weiss T. M., Yang L., Huang H. W. (2000): Membrane thinning effect of the beta-sheet antimicrobial protegrin. Biochemistry 39, 139-145; doi:10.1021/bi991892m
36. Hickel A., Danner S., Amenitsch H., Degovics G., Rappolt M., Lohner K., Pabst G. (2008): Influence of antimicrobial peptides on the formation of nonlamellar lipid mesophases. Biochim. Biophys. Acta 1778, 2325-2333; doi:10.1016/j.bbamem.2008.05.014
37. Howe R. A., Monk A., Wootton M., Walsh T. R., Enright M. C. (2004): Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg. Infect. Dis. 10, 855-857
38. Huang H. W. (2006): Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta 1758, 1292-1302; doi:10.1016/j.bbamem.2006.02.001
39. Hrubšová A., Karlovská J., Devínsky F., Lacko I., Balgavý P. (2003): Solubilization of unilamellar egg yolk phosphatidylcholine liposomes by N-alkyl-N,N-dimethylamine N-oxides. Ceska Slov. Farm. 52, 299-305 (in Czech)
40. Israelachvili J. N., Marcelja S., Horn R. G. (1980): Physical principles of membrane organization. Q. Rev. Biophys. 13, 121-200; doi:10.1017/ S0033583500001645
41. Karlovská J., Lohner K., Degovics G., Lacko I., Devínsky F., Balgavý P. (2004): Effects of non-ionic surfactants N-alkyl-N,N-dimethylamine-N-oxides on the structure of a phospholipid bilayer: small-angle X-ray diffraction study. Chem. Phys. Lipids 129, 31-41; doi:10.1016/j.chemphyslip.2003.11.003
42. Keller S. L., Gruner S. M., Gawrisch K. (1996): Small concentrations of alamethicin induce a cubic phase in bulk phosphatidylethanolamine mixtures. Biochim. Biophys. Acta 1278, 241-246; doi:10.1016/0005-2736(95)00229-4
43. Killian J. A. (2003): Synthetic peptides as models for intrinsic membrane proteins. FEBS Lett. 555, 134-138; doi:10.1016/S0014-5793(03)01154-2
44. Konovalov O., Myagkov I., Struth B., Lohner K. (2002): Lipid discrimination in phospholipid monolayers by the antimicrobial frog skin peptide, PGLa. A synchrotron X-ray grazing incidence and reflectivity study. Eur. Biophys. J. 31, 428-437; doi:10.1007/s00249-002-0233-3
45. Kragh-Hansen U., le Maire M., Moller J. V. (1998): The mechanism of detergent solubilization of liposomes and protein-containing membranes. Biophys. J. 75, 2932-2946; doi:10.1016/S0006-3495(98)77735-5
46. Latal A., Lehrer R. I., Harwig S. S., Lohner K. (1996): Interaction of enantiomeric protegrins with liposomes. Prog. Biophys. Mol. Biol. 65, 121
47. Latal A., Degovics G., Epand R. F., Epand R. M., Lohner K. (1997): Structural aspects of the interaction of peptidyl-glycyl-leucine-carboxyamide, a highly potent antimicrobial peptide from frog skin, with lipids. Eur. J. Biochem. 248, 938-946; doi:10.1111/j.1432-1033.1997.00938.x
48. Li C., Salditt T. (2006): Structure of magainin and alamethicin in model membranes studied by x-ray reflectivity. Biophys. J. 91, 3285-3300; doi:10.1529/biophysj.106.090118 (Pubitemid 44788263)
49. Lohner K. (1991): Effects of small organic molecules on phospholipid phase transitions. Chem. Phys. Lipids 57, 341-362; doi:10.1016/0009-3084(91) 90085-P
50. Lohner K., Degovics G., Laggner P., Gnamusch E., Paltauf F. (1993): Squalene promotes the formation of non-bilayer structures in phospholipid model membranes. Biochim. Biophys. Acta 1152, 69-77; doi:10.1016/0005-2736(93)90232- 90240
51. Lohner K. (1996): Is the high propensity of ethanolamine plasmalogens to form non-lamellar lipid structures manifested in the properties of biomembranes? Chem. Phys. Lipids 81, 167-184; doi:10.1016/0009-3084(96)02580-7
52. Lohner K., Latal A., Lehrer R. I., Ganz T. (1997): Differential scanning microcalorimetry indicates that human defensin, HNP-2, interacts specifically with biomembrane mimetic systems. Biochemistry 36, 1525-1531; doi:10.1021/bi961300p (Pubitemid 27074977)
53. Lohner K., Prenner E. J. (1999): Differential scanning calorimetry and X-ray diffraction studies of the specificity of the interaction of antimicrobial peptides with membrane-mimetic systems. Biochim. Biophys. Acta 1462, 141-156; doi:10.1016/S0005-2736(99)00204-7
54. Lohner K. (2001a): Development of Novel Antimicrobial Agents: Emerging Strategies. Horizon Scientific Press, Wymondham, Norfolk, U.K.
55. Lohner K. (2001b): The role of membrane lipid composition in cell targeting of antimicrobial peptides. In: Development of Novel Antimicrobial Agents: Emerging Strategies, pp. 149-165, Horizon Scientific Press, Wymondham, Norfolk, U.K.
56. Lohner K., Blondelle S. E. (2005): Molecular mechanisms of membrane perturbation by antimicrobial peptides and the use of biophysical studies in the design of novel peptide antibiotics. Comb. Chem. High Throughput Screen. 8, 239-255; doi:10.2174/1386207053764576
57. Ludtke S., He K., Huang H. W. (1995): Membrane thinning caused by magainin 2. Biochemistry 34, 16764-16769doi:10.1021/bi00051a026
58. Ludtke S. J., He K., Heller W. T., Harroun T. A., Yang L., Huang H. W. (1996): Membrane pores induced by magainin. Biochemistry 35, 13723-13728; doi:10.1021/bi9620621 (Pubitemid 26363914)
59. Matsumoto K., Kusaka J., Nishibori A., Hara H. (2006): Lipid domains in bacterial membranes. Mol. Microbiol. 61, 1110-1117; doi:10.1111/j.1365-2958. 2006.05317.x
60. Matsuzaki K., Murase O., Miyajima K. (1995): Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry 34, 12553-12559; doi:10.1021/bi00039a009
61. Matsuzaki K., Murase O., Fujii N., Miyajima K. (1996): An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry 35, 11361-11368; doi:10.1021/bi960016v (Pubitemid 26299310)
62. Matsuzaki K., Sugishita K., Harada M., Fujii N., Miyajima K. (1997): Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta 1327, 119-130; doi:10.1016/S0005-2736(97)00051-55
63. Matsuzaki K., Sugishita K., Ishibe N., Ueha M., Nakata S., Miyajima K., Epand R. M. (1998): Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37, 11856-11863; doi:10.1021/bi980539y
64. Matsuzaki K. (2001): Molecular mechanisms of membrane perturbation by antimicrobial peptides. In: Development of Novel Antimicrobial Agents: Emerging Strategies. (Ed. K. Lohner), pp. 167-181, Horizon Scientific Press, Wymondham, Norfolk, U.K.
65. McElhaney R. N. (1992): Membrane structure. In: Mycoplasmas: Molecular Biology and Pathogenesis. (Eds. J. Maniloff, R. N. McElhaney, L. R. Finch and J. B. Baseman), pp. 113-155, American Society for Microbiology, Washington DC
66. Mileykovskaya E., Dowhan W. (2005): Role of membrane lipids in bacterial division-site selection. Curr. Opin. Microbiol. 8, 135-142; doi:10.1016/j.mib. 2005.02.012
67. Mileykovskaya E., Dowhan W. (2000): Visualization of phospholipid domains in Escherichia coli by using the cardiolipin-specific fluorescent dye 10-N-nonyl acridine orange. J. Bacteriol. 182, 1172-1175; doi:10.1128/JB.182.4. 1172-1175.2000 (Pubitemid 30075045)
68. Mileykovskaya E., Sun Q., Margolin W., Dowhan W. (1998): Localization and function of early cell division proteins in filamentous Escherichia coli cells lacking phosphatidylethanolamine. J. Bacteriol. 180, 4252-4257 (Pubitemid 28373532)
69. Morein S., Andersson A., Rilfors L., Lindblom G. (1996): Wildtype Escherichia coli cells regulate the membrane lipid composition in a "window" between gel and non-lamellar structures. J. Biol. Chem. 271, 6801-6809; doi:10.1074/jbc.271.12.6801
70. Nakamura T., Furunaka H., Miyata T., Tokunaga F., Muta T., Iwanaga S., Niwa M., Takao T., Shimonishi Y. (1988): Tachyplesin, a class of antimicrobial peptide from the hemocytes of the horseshoe crab (Tachypleus tridentatus). Isolation and chemical structure. J. Biol. Chem. 263, 16709-16713
71. Nordberg P., Monnet D. L., Cars O. (2005): Antibacterial Drug Resistance: Options for Concerned Action. WHO, Department of Medicines Policy and Standards
72. Norris V., Fishov I. (2001): Hypothesis: membrane domains and hyperstructures control bacterial division. Biochimie 83, 91-97; doi:10.1016/S0300-9084(00)01203-7 (Pubitemid 32181529)
73. Oren Z., Shai Y. (2001): Molecular mechanism of cell selectivity by linear amphipatic α-helical and diasteriomeric antimicrobial peptides. In: Development of Novel Antimicrobial Agents: Emerging Strategies. (Ed. K. Lohner), pp. 183-204, Horizon Scientific Press, Wymondham, Norfolk, U.K.
74. Pabst G., Danner S., Podgornik R., Katsaras J. (2007): Entropy-driven softening of fluid lipid bilayers by alamethicin. Langmuir 23, 11705-11711; doi:10.1021/la701586c (Pubitemid 350133018)
75. Pabst G., Grage S., Danner-Pongratz S., Jing W., Ulrich A. S., Watts A., Lohner K., Hickel A. (2008): Membrane thickening by the antimicrobial peptide PGLa. Biophys. J. 95, 5779-5788; doi:10.1529/biophysj.108.141630
76. Powers J. P. S., Hancock R. E. W. (2003): The relationship between peptide structure and antibacterial activity. Peptides 24, 1681-1691; doi:10.1016/j.peptides.2003.08.023
77. Rappolt M., Hickel A., Bringezu F., Lohner K. (2003): Mechanism of the lamellar/inverse hexagonal phase transition examined by high resolution x-ray diffraction. Biophys. J. 84, 3111-3122; doi:10.1016/S0006-3495(03)70036-8 (Pubitemid 36531759)
78. Rietveld A. G., Koorengevel M. C., de Kruijff B. (1995): Non-bilayer lipids are required for efficient protein transport across the plasma membrane of Escherichia coli. EMBO J. 14, 5506-5513
79. Rilfors L., Wieslander A., Lindblom G. (1993): Mycoplasma cell membranes. In: Subcellular Biochemistry. (Ed. S. Rottem and I. Kahane), Vol.20, pp. 109-166, Plenum Press, New York
80. Rothman J. E., Leonard J. (1977): Membrane asymmetry. Science 195, 743-753; doi:10.1126/science.402030
81. Rowe E. S. (1983): Lipid chain length and temperature dependence of ethanol-phosphatidylcholine interactions. Biochemistry 22, 3299-3305; doi:10.1021/bi00283a001
82. Seddon J. M., Templer R. H. (1995): Polymorphism of lipid-water systems. In: Handbook of Biological Physics: Structure and Dynamics of Membranes. (Eds. R. Lipowsky and E. Sackmann), pp. 97-160, Elsevier SPC, Amsterdam
83. Sevcsik E., Pabst G., Jilek A., Lohner K. (2007): How lipids influence the mode of action of membrane-active peptides. Biochim. Biophys. Acta 1768, 2586-2595; doi:10.1016/j.bbamem.2007.06.015
84. Sevcsik E., Pabst G., Richter W., Danner S., Amenitsch H., Lohner K. (2008): Interaction of LL-37 with model membrane systems of different complexity: influence of the lipid matrix. Biophys J. 94, 4688-4699; doi:10.1529/biophysj.107.123620
85. Shai Y. (2002): Mode of action of membrane active antimicrobial peptides. Biopolymers 66, 236-248; doi:10.1002/bip.10260
86. Siegel D. P., Banschbach J. L. (1990): Lamellar/inverted cubic (Lα/QII) phase transition in N-methylateddioleoylphosphatidylethanolamine. Biochemistry 29, 5975-5981; doi:10.1021/bi00477a014
87. Simon S. A., McIntosh T. J. (1984): Interdigitated hydrocarbon chain packing causes the biphasic transition behavior in lipid/alcohol suspensions. Biochim. Biophys. Acta 773, 169-172; doi:10.1016/0005-2736(84)90562-5
88. Smith R. D., Coast J. (2002): Antimicrobial resistance: a global response. Bull. WHO 80, 126-133
89. Staudegger E., Prenner E. J., Kriechbaum M., Degovics G., Lewis R. N. A. H., McElhaney R. N., Lohner K. (2000): X-ray studies on the interaction of gramicidin S with microbial lipid extracts: evidence for cubic phase formation. Biochim. Biophys. Acta 1468, 213-230; doi:10.1016/S0005-2736(00)00260-261
90. Strandberg E., Wadhwani P., Tremouilhac P., Durr U. H., Ulrich A. S. (2006): Solid-state NMR analysis of the PGLa peptide orientation in DMPC bilayers: structural fidelity of 2H-labels versus high sensitivity of 19F-NMR. Biophys. J. 90, 1676-1686; doi:10.1529/biophysj.105.073858
91. Uhríková D., Kučerka N., Islamov A., Gordeliy V., Balgavý P. (2001): Small-angle neutron scattering study of N-dodecyl-N,N-dimethylamine N-oxide induced solubilization of dioleoylphosphatidylcholine bilayers in liposomes. Gen. Physiol. Biophys. 20, 183-189
92. Vanounou S., Parola A. H., Fishov I. (2003): Phosphatidylethanolamine and phosphatidylglycerol are segregated into different domains in bacterial membrane. A study with pyrene-labelled phospholipids. Mol. Microbiol. 49, 1067-1079; doi:10.1046/j.1365-2958.2003.03614.x
93. White S. H., Wimley W. C., Selsted M. E. (1995): Structure, function, and membrane integration of defensin. Curr. Opin. Struct. Biol. 5, 521-527; doi:10.1016/0959-440X(95)80038-7
94. Wu Y., He K., Ludtke S. J., Huang H. W. (1995): X-ray diffraction study of lipid bilayer membranes interacting with amphiphilic helical peptides: diphytanoyl phosphatidylcholine with alamethicin at low concentrations. Biophys. J. 68, 2361-2369; doi:10.1016/S0006-3495(95)80418-2
95. Yang L., Harroun T. A., Weiss T. M., Ding L., Huang H. W. (2001): Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 81, 1475-1485; doi:10.1016/S0006-3495(01)
96. Yorek M. A. (1993): Biological distribution. In: Phospholipids Handbook. (Ed. G. Cevc), pp. 745-775, Marcel Dekker, Inc., New York
97. Zasloff M. (2002): Antimicrobial peptides of multicellular organisms. Nature 415, 389-395; doi:10.1038/415389a
98. Zweytick D., Tumer S., Blondelle S. E., Lohner K. (2008): Membrane curvature stress and antibacterial activity of lactoferricin derivatives. Biochem. Biophys. Res. Commun. 369, 395-400; doi:10.1016/j.bbrc.2008.01.176